Ondine Biomedical Inc. (AIM:OBI)

United States Steel Revenue

In the year 2024, Ondine Biomedical had annual revenue of 2.05M CAD with 70.32% growth. Ondine Biomedical had revenue of 1.19M in the half year ending December 31, 2024, with 216.49% growth.

• Revenue: 2.05M CAD
• Revenue Growth: +70.32%
• P/S Ratio: 52.72
• Revenue / Employee: 113.83K CAD
• Employees: 18
• Market Cap: 59.97M USD

Revenue Chart

* This company reports financials in CAD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	2.05M	846.00K	70.32%
Dec 31, 2023	1.20M	565.00K	88.56%
Dec 31, 2022	638.00K	-1.93M	-75.17%
Dec 31, 2021	2.57M	778.00K	43.44%
Dec 31, 2020	1.79M	258.16K	16.84%